3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
42
Breast Neoplasms
32
Neoplasms
29
Melanoma
22
Neoplasm Metastasis
21
Leukemia, Myeloid, Acute
21
Multiple Myeloma
17
Lung Neoplasms
17
Prostatic Neoplasms
16
Colorectal Neoplasms
16
Ovarian Neoplasms
14
Myelodysplastic Syndromes
13
Squamous Cell Carcinoma of Head and Neck
12
Recurrence
12
Lymphoma, Non-Hodgkin
12
Carcinoma, Renal Cell
11
Pancreatic Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
10
Glioblastoma
10
Brain Neoplasms
10
Urinary Bladder Neoplasms
9
Uterine Cervical Neoplasms
8
Stomach Neoplasms
8
Carcinoma, Hepatocellular
8
Rectal Neoplasms
7
Lymphoma
7
Hodgkin Disease
7
Head and Neck Neoplasms
7
Glioma
7
Endometrial Neoplasms
7
Interventions
tusamitamab ravtansine
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Non-small Cell Lung Cancer Metastatic
×
90 days
×
Clear all
NCT04154956
2026-05-18
CARMEN-LC03
Sanofi
Phase 3
Terminated
389 enrolled
16 charts